Figure 2. Numbers of Clinical Trials of Insulin-Like Growth Factor-1 Receptor (IGF-1R) Inhibitors.
A, Number of clinical trials of IGF-1R inhibitors distinguished by phase, initiated in the period 2003 to 2015. B, Number of clinical trials started using combinations of an IGF-1R inhibitor with other anticancer drugs. Details on these trials are reported in eTables 1 and 2 in Supplement 2.